Skip to main content

Year: 2021

Worthington Industries Announces New Tools and Outdoor Living Products Available at Retailers Nationwide

Digital Fuel Gauge, Locking Contour Gauge, Cordless Shearing Tool and Soil Thermometer Reflect Company’s Innovation StrategyBernzomatic® Digital Fuel GaugeMeasures the amount of fuel remaining in 14 oz. or 16 oz. cylinders.General Tools ANGLE-IZER® Locking Contour GaugePrecise shape duplication with locking function for accurate cutting.PacTool Snapper Shear™ Siding ProCompact siding shear attachment for any 18-volt cordless drill.Garden Weasel® Long Stem Soil ThermometerLong-stem, stainless steel probe provides accurate soil temperature.COLUMBUS, Ohio, Nov. 04, 2021 (GLOBE NEWSWIRE) — Worthington Industries, Inc. [NYSE: WOR] today announced new tools and outdoor living products available at retail stores nationwide in time for the holiday season. The new products...

Continue reading

Tuesday Morning Corporation Announces First Quarter Fiscal 2022 Results

Comparable store sales increased 3.2% versus Q1 fiscal 2020 Completed bankruptcy process with $14 million in cash released to the Company DALLAS, Nov. 04, 2021 (GLOBE NEWSWIRE) — Tuesday Morning Corporation (NASDAQ: TUEM), a leading off-price retailer of home goods and décor, today announced its results for the first quarter of fiscal 2022 ended September 30, 2021. Fred Hand, Chief Executive Officer, stated, “I am pleased with our first quarter performance as we exceeded both our Sales and financial plan and successfully completed the bankruptcy process in line with our expectations. Despite the ongoing global supply chain dislocation, we believe the quality and level of our inventories has us properly positioned as we enter the holiday season.” Mr. Hand, continued, “We are in the very early stages of our transformation, and we...

Continue reading

Himax Technologies, Inc. Reports Third Quarter 2021 Financial Results; Provides Fourth Quarter 2021 Guidance

Company Q3 2021 Financial Result met the Guidance; Revenues, Gross Margin and EPS All Reached All-Time Highs Provides Q4 2021 Guidance: Revenues to Increase by 4% to 8% sequentially, Non-IFRS Gross Margin is expected to be around 50%, Non-IFRS Profit per Diluted ADS to be around 78.0 Cents to 83.0 CentsQ3 financial result met the guidance; Revenues, GM and EPS all reached all-time highs Q3 revenues was $420.9M, an increase of 15.2% QoQ and up 75.4% YoY. Q3 GM reached 51.7%, up from the 47.5% in Q2 2021 Q3 Non-IFRS after-tax profit was $138.9M, or 79.5 cents per diluted ADS Q4 revenues to increase by 4% to 8% QoQ. Non-IFRS GM around 50%. Non-IFRS profit attributable to shareholders to be in the range of 78.0 to 83.0 cents per fully diluted ADS. IFRS profit in the range of 74.5 to 79.5 cents per fully diluted ADS  Himax has leading share...

Continue reading

Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment

Studies show that 13-20% of Canadians suffer from IBS at any given time1.The lifetime risk for a Canadian to develop IBS is 30%1.IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ: BMRA) today announced that the Canadian Patent Office has issued a notice of allowance for Biomerica’s patent application pertaining to the Company’s InFoods® diagnostic guided therapy platform technology that offers a novel approach in the treatment of patients suffering from Irritable Bowel Syndrome (“IBS”). IBS is a chronic, often debilitating, functional gastrointestinal (“GI”) disorder with symptoms that include abdominal pain, bloating, and altered bowel behaviors, such as constipation and/or diarrhea, or alternating between the two. This allowed patent contains claims that broadly cover a method that enables physicians...

Continue reading

Progenity Announces Appointment of Jill Howe to its Board of Directors

SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Jill Howe to its board of directors effective November 3, 2021. Ms. Howe was also appointed chairperson of the Audit Committee and member of the Nominating and Corporate Governance Committee. “As Progenity continues to execute its strategic transformation, we are adding key leadership capabilities that will allow us to continue accelerating our efforts to develop the drug discovery and delivery systems of the future,” said Eric d’Esparbes, interim CEO of Progenity. “Jill brings proven financial leadership and extensive pharmaceutical industry experience, which will be invaluable in her role as chair of the Audit Committee for Progenity.” “It’s an exciting time for Progenity as there is incredible...

Continue reading

Integra Intersects 3.36 g/t AuEq Over 92.66 m, Including 24.15 g/t AuEq Over 7.01 m and 1.18 g/t AuEq Over 44.81 m, Including 4.21 g/t AuEq Over 10.82 m at Florida Mountain

Drill results from the Florida Mountain Deposit include:FME-21-115: 3.15 grams per tonne (“g/t”) gold (“Au”) and 16.63 g/t silver (“Ag”) (3.36 g/t gold equivalent (“AuEq”)) over 92.66 meters (“m”)Including 68.88 g/t Au and 135.00 g/t Ag (70.62 g/t AuEq) over 1.53 m Including 23.25 g/t Au and 70.04 g/t Ag (24.15 g/t AuEq) over 7.01 m Including 67.16 g/t Au and 208.00 g/t Ag (69.84 g/t AuEq) over 1.53 m Including 28.44 g/t Au and 40.14 g/t Ag (28.96 g/t AuEq) over 1.22 mFME-21-119: 3.06 g/t Au and 24.70 Ag (3.37 g/t AuEq) over 10.52 mIncluding 22.67 g/t Au and 186.00 g/t Ag (25.06 g/t AuEq) over 1.22 mFME-21-119: 0.87 g/t Au and 24.64 g/t Ag (1.18 g/t AuEq) over 43.59 mIncluding 5.25 g/t Au and 341.00 g/t Ag (9.64 g/t AuEq) over 0.61 mFME-21-117: 0.80 g/t Au and 68.77 g/t Ag (1.69 g/t AuEq) over 22.86 mFME-21-125:...

Continue reading

Blucora Announces Third Quarter 2021 Results

DALLAS, Nov. 04, 2021 (GLOBE NEWSWIRE) — Blucora, Inc. (NASDAQ: BCOR), a leading provider of technology-enabled, tax focused financial solutions, today announced financial results for the third quarter ended September 30, 2021. Third Quarter Highlights and Recent DevelopmentsTotal revenue for the quarter was $174.2 million GAAP Net Loss of $27.8 million, or $(0.57) per diluted share Non-GAAP Net Loss of $12.8 million, or $(0.26) per diluted share Total client assets ended the quarter up 14% year-over-year to $86.6 billion, with $39.8 billion, or 45.9% in advisory assets Advisory assets increased 23% year-over-year, including approximately $5.4 billion in Avantax Planning Partners (“APP”) assets Preliminary outlook for the tax software segment projects revenue growth of between 14% and 18% from the mid-point of our 2021 full-year...

Continue reading

CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases

Providing Global Clinical Trial Support for Thalassemia and Sickle Cell Disease Will Deepen Understanding of Disease Characterization in the Search for a Treatment CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, Nov. 04, 2021 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced today that it has expanded its partnership with Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism developing and delivering innovative treatments for genetically defined diseases. Under the terms of the new agreement, CENTOGENE will provide genetic testing and clinical trial support for Agios’ three global, pivotal trials in thalassemia and sickle cell disease. Under a previous agreement, CENTOGENE...

Continue reading

KVH Industries Reports Third Quarter 2021 Results

MIDDLETOWN, R.I., Nov. 04, 2021 (GLOBE NEWSWIRE) — KVH Industries, Inc., (Nasdaq: KVHI), reported financial results for the quarter ended September 30, 2021 today. The company will hold a conference call to discuss these results at 9:00 a.m. ET today, which can be accessed at investors.kvh.com. Following the call, a replay of the webcast will be available through the company’s website. Third Quarter 2021 HighlightsTotal revenues increased by 5% in the third quarter of 2021 to $43.0 million from $41.1 million in the third quarter of 2020.Revenues for AgilePlans, our Connectivity as a Service program for the commercial maritime sector, were up more than 54% compared to the third quarter of 2020. AgilePlans now represent 47% of our mini-VSAT Broadband subscriber base.Our mini-VSAT Broadband airtime revenue increased $2.9 million,...

Continue reading

Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Urologists’ Access to Procedural Expertise

Innovative, cloud-based digital platform supports Urologists’ access to enhanced training with the UroLift® System through remote collaboration tools WAYNE, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it is combining its leading industry clinical education with the digital platform of Explorer Surgical, a GHX company. This collaboration will provide Urologists expanded access to interactive training and remote learning opportunities for the Teleflex UroLift® System.  The Explorer Live cloud-based digital platform communicates critical information through an interactive digital playbook, enabling surgical teams to access customized information for specific team roles. The platform facilitates UroLift System trainer collaboration with Urology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.